Drug intelligence / Profile preview

bovine insulin

Development stage
Discontinued
Lead developer
Eli Lilly
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous, Intravenous, Intramuscular
01

Overview

Bovine insulin is a peptide hormone produced by the beta cells of the pancreatic islets in cattle. It consists of two polypeptide chains (A and B) linked by disulfide bonds and differs from human insulin by three amino acid residues[2][8]. As the main anabolic hormone in mammals, it regulates carbohydrate, fat, and protein metabolism primarily by promoting glucose uptake into liver, muscle, and adipose tissue. Historically used to treat diabetes mellitus before recombinant human insulins became widely available, bovine insulin remains clinically effective for some patients who cannot tolerate human or porcine insulins[1][3]. However, it is more immunogenic than highly purified human insulins[5]. Its use has declined significantly due to concerns about immunogenicity and potential transmission of diseases such as bovine spongiform encephalopathy (BSE)[1][4]. Some formulations have been discontinued due to raw material shortages[4].

Brand names
Hypurin Bovine IsophaneHypurin Bovine Lente
Other names
beef insulininsulin bovine
02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)INSR (Insulin receptor)

Beyond the preview

Go deeper on bovine insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bovine insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call